Study for ERBB2 gene detection kit (fluorescence in situ hybridization)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000031600

Enrollment

Unknown

Registered

2020-04-05

Start date

2020-05-06

Completion date

Unknown

Last updated

2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Gold Standard:ERBB2 (FISH) produced by other company

Index test:ERBB2&#32

(FISH),&#32

produced&#32

by&#32

Guangzhou&#32

LBP&#32

Medical&#32

Technology&#32

Co.,Ltd.&#32

China

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Cases with a clinical pathological diagnosis of breast cancer, 2. Samples of different pathological types and grades.

Exclusion criteria

Exclusion criteria: 1. Breast cancer tissue sections cannot meet the testing requirements; 2. Those who do not meet the selection criteria.

Design outcomes

Primary

Measure	Time frame
ERBB2;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactZhang Zhang

West China Hospital, Sichuan University

zhangzhang714@163.com+86 18980606784

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026